TCOYD SPONSOR HIGHLIGHT

Xeris Pharmaceuticals, Inc., the maker of Gvoke HypoPen®, is dedicated to unlocking the potential of glucagon. We believe that easier-to-use medicines can have a profound impact on the lives of patients and their families. That is why our first products to market are liquid glucagon, but that is just the beginning. We are also studying how our formulation technology can impact patients with other conditions. We have a persistent drive to pursue advancements that have the potential to change lives.

EVERYTHING YOU NEED TO KNOW ABOUT Gvoke HypoPen®

USING GVOKE TO MANAGE YOUR DIABETES: PRESENTED BY TCOYD FACULTY

EDUCATIONAL VIDEOS

EDUCATIONAL ARTICLES

“Expect the Unexpected When It Comes to Severe Hypoglycemia in T2D”

READ ARTICLE

“Educate Your Inner Circle on Hypoglycemia: It Could Save Your Life!”

READ ARTICLE

“Treating a Low: When to Consume Sugar & When to Use Glucagon”

READ ARTICLE

“A Renaissance in Glucagon: Ready to Use, Ready to Have!”

READ ARTICLE

“The New Normal: Glucagon Ready to Go”

READ ARTICLE

traveling and diabetes

“Traveling with Diabetes: 7 Tips to Know Before You Go”

READ ARTICLE

“Lifesaving Tools to Prevent and Treat Hypoglycemia”

READ ARTICLE

FOLLOW GVOKE & XERIS